Buscar
Mostrando ítems 1-10 de 1746
Pulmonary fibrosis secondary to COVID-19: a narrative review
(2021-01-01)
Introduction: Coronavirus disease 2019 (COVID-19) is still increasing worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to COVID-19 will expand over time. Risk factors, histopathological ...
Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis
(Facultad de Medicina y Ciencia, 2019)
Introduction: There is evidence of an association between inflammatory bowel disease (IBD) and lung conditions such as chronic obstructive pulmonary disease (COPD). This systematic review and meta-analysis explored the ...
Management of NCD in low- And middle-income countries
(Elsevier, 2014)
Noncommunicable disease (NCD), comprising cardiovascular disease, stroke, diabetes, and chronic obstructive pulmonary disease, are increasing in incidence rapidly in low- and middle-income countries (LMICs). Some patients ...
Smoking and chronic obstructive pulmonary disease: Attributable risk determination Tabaquismo y enfermedad pulmonar obstructiva crónica: Determinación de fracciones atribuibles
(2006)
Background: Smoking is the main risk factor for Chronic Obstructive Pulmonary Disease (COPD), an important cause of morbidity and mortality. Aim: To estimate smoking attributable risk and population attributable risk in ...
Biomass smoke as a risk factor for chronic obstructive pulmonary disease: Effects on innate immunity
(SAGE Publications Ltd, 2016)
Diagnosis of pulmonary embolism in patients with acute exacerbations of chronic obstructive pulmonary disease: a cross-sectional study
(Wiley Blackwell Publishing, Inc, 2020-12)
Introduction: Pulmonary embolism (PE) remains a frequent complication in patients with chronic obstructive pulmonary disease (COPD). It is unclear that the extent to which the traditional risk stratifying scores for PE are ...